Provided by Tiger Fintech (Singapore) Pte. Ltd.

CureVac B.V.

5.47
+0.01000.18%
Pre-market: 5.480.0100+0.18%08:17 EDT
Volume:458.13K
Turnover:2.51M
Market Cap:1.23B
PE:6.31
High:5.50
Open:5.47
Low:5.45
Close:5.46
Loading ...

CureVac Nv - Part B of Gliosblastoma Study First Data Readout Anticipated in H2 2025

THOMSON REUTERS
·
10 Apr

CureVac Nv - Company Reaffirms Its Expected Cash Runway Into 2028

THOMSON REUTERS
·
10 Apr

CureVac Nv - in 2024, Cash Used in Operations Was Mainly Allocated to Extraordinary Payments Amounting to a Total of EUR 137 Mln

THOMSON REUTERS
·
10 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
10 Apr

CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025

ACCESS Newswire
·
08 Apr

CureVac Receives FDA Clearance to Initiate Phase 1 Trial of Lung Cancer Therapy

MT Newswires Live
·
07 Apr

CureVac Gets U.S. FDA Ind Clearance to Initiate Phase 1 Clinical Trial for Novel Mrna-Based Precision Immunotherapy in Sqnsclc

THOMSON REUTERS
·
07 Apr

CureVac Nv - Patient Treatment Anticipated to Start in Second Half of 2025

THOMSON REUTERS
·
07 Apr

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer

ACCESS Newswire
·
07 Apr

Is CureVac (CVAC) the Best German Stock to Buy According to Hedge Funds?

Insider Monkey
·
03 Apr

CureVac (CVAC) Gets a Hold from Leerink Partners

TIPRANKS
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-GameStop, Oxford Industries, Wolfspeed

Reuters
·
29 Mar

CureVac Shares Rise on Patent Confirmation Amid BioNTech Lawsuit

Dow Jones
·
29 Mar

U.S.-Listed Shares of CureVac Rise 15.3% After Co's Mrna Patent Upheld by European Patent Office

THOMSON REUTERS
·
28 Mar

U.S.-Listed Shares of CureVac Rise 16% Premarket After Co's Mrna Patent Upheld by European Patent Office

THOMSON REUTERS
·
28 Mar

BUZZ-U.S. STOCKS ON THE MOVE -CureVac, gold miners, Rocket Lab

Reuters
·
28 Mar

CureVac Patent Validated in BioNTech Dispute, Infringement Hearing Set for July

MT Newswires Live
·
28 Mar

CureVac says European Patent Office dismissed BioNTech opposition

TIPRANKS
·
28 Mar

BUZZ-CureVac rises on COVID vaccine patent decision

Reuters
·
28 Mar

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

ACCESS Newswire
·
28 Mar